<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>1</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2000</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">ADENYLYL CYCLASE ASSAYS TO MEASURE MACROPHAGE CHEMOTACTIC PROTEIN-1 RECEPTOR FUNCTION</title>
    <FirstPage>97</FirstPage>
    <LastPage>100</LastPage>
    <AuthorList>
      <Author>
        <FirstName></FirstName>
        <LastName>Durdi Qujeq</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>Majid Ahmadi</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Adenylyl cyclase is a membrane-bound enzyme that catalyzes the conversion of ATP to cAMP. The inhibition of adenylyl cyclase was carried out by measuring the ability of the macrophage chemotactic protein-1 to inhibit the torskolin-induced enzyme activity. Adenylyl cyclase activity in the presenc of macrophage chemotactic protein-1 was decreased compared to that in controls [2.11+/-0.15 (mean +/- SD.) vs. 6.83 +/- 0.45, activity (/nnol cAMP/mg protein/min).</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/17</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/17/17</pdf_url>
  </Article>
</Articles>
